Contact Cecilia Arradaza Communications Director FasterCures : 202.336.8912 : carradaza@fastercures.org

Medical Research Innovators and Investors Convene at Partnering for Cures in New York to Focus on Collaborative Solutions

WASHINGTON - Hundreds of leaders from all sectors in medical research will gather at the 3rd annual Partnering for Cures meeting to focus on developing and amplifying collaborative solutions needed to accelerate medical progress. This outcomes-driven meeting will be held November 7-8, 2011 at the Grand Hyatt New York.

Developing a viable medical solution could take an average of 15 years, $1.3 Billion, and a long list of innovative approaches to increase the odds of successfully moving therapies from the laboratory bench to the patient's bedside. For two days, medical research and development decision-makers, innovators, and investors will come together to find nontraditional partners, explore collaborative approaches, and create new business models vital to speeding up the time it takes to get important new medicines from discover to patients.

It features 16 panels focused on addressing some of medical research's top concerns in concrete ways; 30 case studies featuring creative, outcomes-driven real-world collaborations; and a customized partnering system designed to connect diverse leaders with shared goals.

• Government Officials

  • Michael Rawlins, Chairman, National Institute of Health and Clinical Excellence
  • Francis Collins, Director, National Institutes of Health
  • Margaret Hamburg, Commissioner, U.S. Food and Drug Administration
  • Biotechnology and Pharmaceutical Company Executives
  • John Mendlein, Executive Chairman, Fate Therapeutics/aTyr Pharma
  • Greg Simon, Senior Vice President, Patient Engagement, Pfizer Inc.
  • Timothy Wright, Senior Vice President and Global Head of Translational Sciences at Novartis Institutes for BioMedical Research
  • James Greenwood, President and CEO, Biotechnology Industry Organization

• Venture Capital Investors

  • Brook Byers, Partner, Kleiner Perkins Caufield & Byers
  • Jonathan Leff, Managing Director, Healthcare, Warburg Pincus
  • Chris Varma, Entrepreneur-in-Residence, Third Rock Ventures

• Academic Leaders

  • Susan Desmond-Hellmann, Chancellor, University of California, San Francisco
  • Gordon R. Bernard, Professor of Medicine, Associate Vice Chancellor for Research, and Senior Associate Dean for Clinical Science, Vanderbilt University
  • Garret FitzGerald, M.D., M.Sc.
  • Robert L. McNeil, Jr., Professor in Translational Medicine and Therapeutics, University of Pennsylvania

• Venture Philanthropy Leaders

  • Robert Beall, President and CEO, Cystic Fibrosis Foundation
  • Jeffrey Brewer, President and CEO, Juvenile Diabetes Research Foundation
  • Kathy Giusti, Founder and Chief Executive Officer, Multiple Myeloma Research Foundation

For a complete list of speakers and the program agenda, please click here.

Partnering for Cures is convened by FasterCures, the Washington-based center of the Milken Institute focused on accelerating discovery and development of new medical solutions.

Note to media: Credentialed members of the press wishing to cover Partnering for Cures, please email Cecilia Arradaza, FasterCures Communications Director, at carradaza@fastercures.org.